Holdings

Novo Holdings A/S

As of Sep 30, 2026, Novo Holdings A/S reported 26 positions worth US$1.46B. Largest: Edgewise Therapeutics, Inc., ASML Holding NV and Brookfield Corporation. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Edgewise Therapeutics, Inc.5.35MUS$217Mno changeSep 30, 2026
ASML Holding NV94,946US$172Mno changeSep 30, 2026
Brookfield Corporation4.47MUS$163M+969KSep 30, 2026
Hemab Therapeutics Holdings, Inc.4.18MUS$129Mno changeSep 30, 2026
Avalyn Pharma Inc.3.45MUS$98.3M−434KSep 30, 2026
Mirum Pharmaceuticals, Inc.1.13MUS$96.2Mno changeSep 30, 2026
Salesforce, Inc.393KUS$90.3Mno changeSep 30, 2026
Enliven Therapeutics, Inc.1MUS$45.8Mno changeSep 30, 2026
4D Molecular Therapeutics, Inc.3MUS$42.9M−249KSep 30, 2026
Obsidian Therapeutics, Inc.3.12MUS$42.9MnewSep 30, 2026